NIHR Signal: Iron deficiency in people with chronic kidney disease can be managed with either oral or IV therapy
Expert commentary is provided for a review of 39 RCTs (n=3,852) which found that death and cardiovascular death rates were not different for IV and oral iron. Questions remain about cost-effectiveness and tolerability of both oral and IV therapies.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Health | Heart | Iron | IV Therapy | National Institute for Health Research (NIHR) | Urology & Nephrology